skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8838

Addiction treatment trials: how gender, race/ethnicity, and age relate to ongoing participation and retention in clinical trials

Original Research

(797) Views  (172) Full article downloads

Authors: Korte JE, Rosa CL, Wakim PG, Perl HI

Published Date November 2011 Volume 2011:2(1) Pages 205 - 218
DOI: http://dx.doi.org/10.2147/SAR.S23796

Jeffrey E Korte1, Carmen L Rosa2, Paul G Wakim2, Harold I Perl2
1Division of Biostatistics and Epidemiology, Medical University of South Carolina, Charleston, SC, 2Center for the Clinical Trials Network, National Institute on Drug Abuse, Bethesda, MD, USA

Introduction: Historically, racial and ethnic minority populations have been underrepresented in clinical research, and the recruitment and retention of women and ethnic minorities in clinical trials has been a significant challenge for investigators. The National Drug Abuse Treatment Clinical Trials Network (CTN) conducts clinical trials in real-life settings and regularly monitors a number of variables critical to clinical trial implementation, including the retention and demographics of participants.
Purpose: The examination of gender, race/ethnicity, and age group differences with respect to retention characteristics in CTN trials.
Methods: Reports for 24 completed trials that recruited over 11,000 participants were reviewed, and associations of gender, race/ethnicity, and age group characteristics were examined along with the rate of treatment exposure, the proportion of follow-up assessments obtained, and the availability of primary outcome measure(s).
Results: Analysis of the CTN data did not indicate statistical differences in retention across gender or race/ethnicity groups; however, retention rates increased for older participants.
Conclusion: These results are based on a large sample of patients with substance use disorders recruited from a treatment-seeking population. The findings demonstrate that younger participants are less likely than older adults to be retained in clinical trials.

Keywords: addiction treatment, age, ethnic minorities, gender difference, substance use disorders, race, recruitment, retention, clinical trials







Readers of this article also read:

Substance abuse and rehabilitation: responding to the global burden of diseases attributable to substance abuse
Willingness to treat drug dependence and depression: comparisons of future health professionals
Improving drug abuse treatment delivery through adoption of harmonized electronic health record systems
The association of family and peer factors with tobacco, alcohol, and marijuana use among Chilean adolescents in neighborhood context
Selective review and commentary on emerging pharmacotherapies for opioid addiction
Against professional advice: treatment attrition among pregnant methamphetamine users
The Global Youth Tobacco Survey: 2001–2002 in Riyadh region, the Kingdom of Saudi Arabia
Promising international interventions and treatment for women who use and abuse drugs: focusing on the issues through the InWomen's Group
Long-term residential substance abuse treatment for women: lessons learned from Israel
Screening for alcohol and drug use disorders among adults in primary care: a review